104 related articles for article (PubMed ID: 2910786)
1. The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy.
Rotmensch J; Atcher RW; Schlenker R; Hines J; Grdina D; Block BS; Press MF; Herbst AL; Weichselbaum RR
Gynecol Oncol; 1989 Feb; 32(2):236-9. PubMed ID: 2910786
[TBL] [Abstract][Full Text] [Related]
2. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma.
Rotmensch J; Atcher RW; Hines J; Grdina D; Schwartz JS; Toohill M; Herbst AL
Am J Obstet Gynecol; 1989 Apr; 160(4):789-97. PubMed ID: 2712112
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
Horak E; Hartmann F; Garmestani K; Wu C; Brechbiel M; Gansow OA; Landolfi NF; Waldmann TA
J Nucl Med; 1997 Dec; 38(12):1944-50. PubMed ID: 9430475
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short-lived high-LET alpha-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma.
Rotmensch J; Atcher RW; Hines J; Toohill M; Herbst AL
Gynecol Oncol; 1989 Dec; 35(3):297-300. PubMed ID: 2599463
[TBL] [Abstract][Full Text] [Related]
6. 211At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y.
Bloomer WD; McLaughlin WH; Lambrecht RM; Atcher RW; Mirzadeh S; Madara JL; Milius RA; Zalutsky MR; Adelstein SJ; Wolf AP
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):341-8. PubMed ID: 6706730
[TBL] [Abstract][Full Text] [Related]
7. Comparison of therapeutic efficacy and biodistribution of 213Bi- and 211At-labeled monoclonal antibody MX35 in an ovarian cancer model.
Gustafsson AM; Bäck T; Elgqvist J; Jacobsson L; Hultborn R; Albertsson P; Morgenstern A; Bruchertseifer F; Jensen H; Lindegren S
Nucl Med Biol; 2012 Jan; 39(1):15-22. PubMed ID: 21958859
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of a radiolabeled monoclonal antibody on human ovarian cancer xenograft in nude mice.
Manetta A; Satyaswaroop PG; Hamilton T; Ozols R; Mortel R
Gynecol Oncol; 1989 Mar; 32(3):368-70. PubMed ID: 2920960
[TBL] [Abstract][Full Text] [Related]
10. Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use.
Napoli E; Bønsdorff TB; Jorstad IS; Bruland ØS; Larsen RH; Westrøm S
PLoS One; 2021; 16(3):e0248133. PubMed ID: 33662039
[TBL] [Abstract][Full Text] [Related]
11. Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
Dijkgraaf I; Kruijtzer JA; Frielink C; Corstens FH; Oyen WJ; Liskamp RM; Boerman OC
Int J Cancer; 2007 Feb; 120(3):605-10. PubMed ID: 17096340
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
[TBL] [Abstract][Full Text] [Related]
13. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
[TBL] [Abstract][Full Text] [Related]
14. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
15. Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vector.
Rogers BE; Curiel DT; Mayo MS; Laffoon KK; Bright SJ; Buchsbaum DJ
Cancer; 1997 Dec; 80(12 Suppl):2419-24. PubMed ID: 9406692
[TBL] [Abstract][Full Text] [Related]
16. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
17. Astatine-211-labeled antibodies for treatment of disseminated ovarian cancer: an overview of results in an ovarian tumor model.
Andersson H; Elgqvist J; Horvath G; Hultborn R; Jacobsson L; Jensen H; Karlsson B; Lindegren S; Palm S
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3914S-21S. PubMed ID: 14506189
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
Cancer Biother Radiopharm; 2000 Feb; 15(1):53-64. PubMed ID: 10740653
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer.
Hu L; Hofmann J; Zaloudek C; Ferrara N; Hamilton T; Jaffe RB
Am J Pathol; 2002 Nov; 161(5):1917-24. PubMed ID: 12414537
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an intraperitoneal ovarian cancer xenograft model in nude rats using noninvasive microPET imaging.
Zavaleta CL; Phillips WT; Bradley YC; McManus LM; Jerabek PA; Goins BA
Int J Gynecol Cancer; 2007; 17(2):407-17. PubMed ID: 17362319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
